ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

10365	Companies
215860	Keywords
145590	Articles
114302	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 05/07/2024 at 22:00, 1 year 11 months ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax informs shareholders of its ordinary and extraordinary general meeting on May 30, 2024, providing access to preparatory documents and details on participation. Obefazimod and Abivax information included

Abivax Obefazimod General Meeting Clinical-stage Biotechnology Preparatory Documents
PRESS RELEASE

published on 05/07/2024 at 22:00, 1 year 11 months ago

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the preparatory documents
Abivax announces its annual ordinary and extraordinary general meeting on May 30, 2024, with preparatory documents available for shareholders. The meeting details, including agenda and resolutions, are accessible on the company's website

Shareholders Biotechnology Abivax General Meeting Preparatory Documents
PRESS RELEASE

published on 05/07/2024 at 22:00, 1 year 11 months ago

Abivax assemblée générale ordinaire annuelle et extraordinaire du 30 mai 2024 - Mise à disposition des documents préparatoires
Abivax annonce son assemblée générale annuelle et extraordinaire du 30 mai 2024 avec la mise à disposition des documents préparatoires. L'événement se tiendra à Paris

Biotechnologie Abivax Assemblée Générale Traitements Thérapeutiques Documents Préparatoires
BRIEF

published on 04/30/2024 at 18:05, 2 years ago

ABIVAX rapporte le nombre d'actions et de droits de vote au 31 mars 2024

Autorité Des Marchés Financiers Droits De Vote Capital Social Abivax Informations Réglementaires
BRIEF

published on 04/30/2024 at 18:05, 2 years ago

ABIVAX reports the number of shares and voting rights as of March 31, 2024

Share Capital Voting Rights Financial Markets Authority Abivax Regulatory Information
PRESS RELEASE

published on 04/30/2024 at 18:00, 2 years ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.24.
ABIVAX communique le nombre d'actions et de droits de vote au 31.03.24, conformément aux dispositions réglementaires. Abivax est une société de biotechnologie axée sur le développement de traitements thérapeutiques

Droits De Vote Capital Social Biotechnologie Abivax Traitements Thérapeutiques
BRIEF

published on 04/05/2024 at 22:05, 2 years 1 month ago

Abivax Announces Submission of Financial Reports to French and U.S. Regulatory Agencies

Abivax Financial Reports Chronic Inflammatory Diseases Regulatory Agencies Webcast Announcement
BRIEF

published on 04/05/2024 at 22:05, 2 years 1 month ago

Abivax annonce la soumission de rapports financiers aux agences de régulation françaises et américaines

Abivax Maladies Inflammatoires Chroniques Rapports Financiers Les Organismes De Réglementation Annonce De Diffusion Web
PRESS RELEASE

published on 04/05/2024 at 22:00, 2 years 1 month ago

Abivax a déposé ses rapports financiers auprès des autorités de marchés financiers française et américaine
Abivax dépose ses rapports financiers auprès des autorités de marchés français et américaine, annonçant la disponibilité de ses documents pour l'année 2023

Biotechnologie Abivax Investisseurs Rapports Financiers Autorités De Marchés
PRESS RELEASE

published on 04/05/2024 at 22:00, 2 years 1 month ago

Abivax publishes financial reports with the French and U.S. securities regulatory agencies
Abivax publishes 2023 financial reports with French and U.S. securities regulators, including annual report and governance information

Abivax Financial Reports Regulatory Agencies French Securities U.S. Securities

Accesswire

Published on 05/07/2026 at 15:15, 23 minutes ago

ACCESS Newswire Launches ACCESS Insights & Analytics, AI-Powered Press Release Scoring Platform
Published on 05/07/2026 at 14:35, 1 hour 3 minutes ago

Worksport (NASDAQ: WKSP) Announces Q1 2026 Earnings Call Date and Launch of Investor Townhall Series
Published on 05/07/2026 at 14:30, 1 hour 8 minutes ago

Rio Grande Resources Announces Results of First Annual General Meeting and Re-Appointments
Published on 05/07/2026 at 14:30, 1 hour 8 minutes ago

Loar Holdings Inc. Reports Q1 2026 Record Results and Upward Revision to 2026 Outlook
Published on 05/07/2026 at 14:00, 1 hour 38 minutes ago

Adcore to Publish First Quarter 2026 Results on May 14, 2026

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 15:28, 10 minutes ago

JOST’s Annual General Meeting approves dividend of EUR 1.50 per share and elects new Supervisory Board member
Published on 05/07/2026 at 15:10, 28 minutes ago

Elevated Materials Appoints Sunit Kapur as Chief Operating Officer
Published on 05/07/2026 at 15:05, 32 minutes ago

CELEBRATING FEET WITH A TOUCH OF COLOR: BIRKENSTOCK INTRODUCES NAIL POLISH COLLECTION
Published on 05/07/2026 at 14:56, 42 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 05/07/2026 at 14:54, 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc

Les Echos

Published on 05/07/2026 at 15:00, 38 minutes ago

Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Published on 05/07/2026 at 07:43, 7 hours 55 minutes ago

ENGIE - Q1 2026 financial information
Published on 05/07/2026 at 07:43, 7 hours 55 minutes ago

ENGIE - Information Financière 1er trimestre 2026
Published on 05/06/2026 at 18:00, 21 hours 38 minutes ago

Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 21 hours 38 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026

View all LES ECHOS COMFI WIRE